The present disclosure provides a method for obtaining osteoblast cell-mixture which can be used for transplantation of osteoblast cells in a subject. The present disclosure further discloses a method for delivering osteoblast cells into a subject. The method for obtaining osteoblast cell-mixture as disclosed herein...

The present disclosure discloses a method for preparing a lysate, from a combination of umbilical cord blood (UCB) and maternal blood (MB) derived platelets by obtaining platelet-rich plasma via sedimentation processes and then mixing platelet-rich plasmas so obtained. The present disclosure further discloses a comb...

The present disclosure discloses a method for isolating osteoprogenitors like mesenchymal stem cells (MSCs) from clotted bone marrow and culturing with a platelet lysate obtained from a combination of discarded umbilical cord blood and maternal blood platelet-rich plasma (instead of non-human animal origin serum) an...

ABSTRACT The invention provides a method for providing an optimized antimicrobial Hematopoietic stem cell CFU Assay by supplementing a Methylcellulose-based CFU assay media with a synergistic antibiotic composition comprising one or more of a ß-lactamase inhibitor and a mixture of ß-lactam antibiotic and an Amino...

The present disclosure discloses a method for isolating osteoprogenitors like mesenchymal stem cells (MSCs) from clotted bone marrow and culturing with a platelet lysate obtained from a combination of discarded umbilical cord blood and maternal blood platelet-rich plasma (instead of non-human animal origin serum) an...

The present disclosure discloses pharmaceutical compositions comprising hematopoietic stem cells (HSC) cells, NK cells, and T cells individually, having positive and negative surface markers and pharmaceutically acceptable excipients. The present disclosure further relates to the method for preparing the composition...

ABSTRACT METHOD FOR PRODUCING MESENCHYMAL STEM CELLS FOR THERAPEUTIC APPLICATIONS The present disclosure relates to a method for producing mesenchymal stem cells for therapeutic applications. The method comprises culturing of MSCs to obtain 5 heterogeneous population. This heterogeneous population of MSCs were subj...

The present disclosure relates to a method of inducing tissue regeneration, said 5 method comprising administering to said tissue a composition comprising a population of mesenchymal stem cells (MSCs) and a carrier, wherein said composition possess an inherent ability to reduce inflammation by increasing levels of I...

ABSTRACT A FORMULATION COMPIRISING A HOMOGENEOUS POPULATION OF MESENCHYMAL STEM CELLS AND IMPLEMENTATIONS THEREOF 5 The present disclosure relates to a formulation comprising: a) a population of mesenchymal stem cells (MSCs); and b) a carrier selected from serelaxin, Ringer’s lactate solution, human serum albu...